Cubist Pharmaceuticals (United States)
Cubist Pharmaceuticals, Inc. was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, Massachusetts. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cubist Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
46%
Total
Publications
629
Total Open
Publications
288
Total
Citations
41K
Open Access
Percentage
46%
Total
Publications
629
Total Open
Publications
288
Total
Citations
41K
Breakdown
Publisher Open
18%
Both
15%
Other Platform Open
13%
Closed
54%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 33%
69
Hybrid 12%
26
No Guarantees 55%
114
Other Platform Open
Domain 68%
121
Other Internet 27%
48
Institution 18%
33
Public 2%
4
Preprint 2%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 121 |
DOI | Other Internet | 46 |
doaj.org OAI-PMH Repository | Institution | 13 |
University of Michigan | Institution | 4 |
The University of Melbourne | Institution | 4 |
Figshare | Public | 4 |
Harvard University | Institution | 3 |
Washington University in St. Louis | Institution | 2 |
Unknown Repository | Other Internet | 2 |
University of Waterloo | Institution | 2 |